Business
Stonegate Capital Partners Initiates Coverage on NeOnc Technologies Holdings, Inc. (NTHI)
Dallas, Texas--(Newsfile Corp. - January 9, 2026) - NeOnc Technologies Holdings, Inc. (NASDAQ: NTHI). Stonegate Capital Partners initiates their coverage on NeOnc Technologies Holdings, Inc. (NASDAQ: NTHI). NeOnc Technologies Holdings, Inc. is a clinical-stage life sciences company developing central nervous system therapeutics designed to overcome the blood-brain barrier. The Company has numerous assets in its pipeline, highlighted by NEO100 which is a patented, pure pharmaceutical...
About this update from Neonc Technologies Holdings, Inc.
[{"type":"text","content":"Dallas, Texas--(Newsfile Corp. - January 9, 2026) - NeOnc Technologies Holdings, Inc. (NASDAQ: NTHI). Stonegate Capital Partners initiates their coverage on NeOnc Technologies Holdings, Inc. (NASDAQ: NTHI). NeOnc Technologies Holdings, Inc. is a clinical-stage life sciences company developing central nervous system therapeutics designed to overcome the blood-brain barrier. The Company has numerous assets in its pipeline, highlighted by NEO100 which is a patented, pure pharmaceutical compound produced via proprietary synthesis for pharmaceutical-grade purity and reproducibility. NeOnc's intranasal administration strategy is designed to access the brain via olfactory and trigeminal pathways, offering a non-invasive route intended to improve adherence and enable more direct delivery. We view NTHI as a differentiated platform, supported by favorable tolerability with prolonged dosing and multiple near-term catalysts as the program advances toward a 2026 readout.","length":976,"tagName":"p"},{"type":"text","content":"To view the full announcement, including downloadable images, bios, and more, click here.","length":89,"tagName":"p"},{"type":"text","content":"Key Takeaways:","length":14,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Positive Phase 1/2a results for NEO100 announced in December","length":60,"tagName":"p"}]},{"val":[{"type":"text","content":"NEO100 Phase 2a top-line read out expected in Mid-2026","length":54,"tagName":"p"}]},{"val":[{"type":"text","content":"Closing and funding of the Quazar Investment expected in the near-term","length":70,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":184,"olType":false},{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","className":"","disableSlideshowImg":false,"size":{"original":{"width":550,"height":172,"url":"https://media.zenfs.com/en/newsfile_64/b6c04b4edf1168428e34ec9e20134192"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/lgT8D_GWfVw.ic_5C5RaEw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTMwMDtjZj13ZWJw/https://media.zenfs.com/en/newsfile_64/b6c04b4edf1168428e34ec9e20134192","width":550,"height":172}},"href":"https://api.newsfilecorp.com/redirect/gJEN3Sye5P","hrefExternal":true},{"type":"text","content":"Click image above to view full announcement.","length":44,"tagName":"p","attribs":{}},{"type":"horizontalRule"},...